These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26832784)

  • 1. Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy.
    Acharya S; Rogers P; Krishnamoorthy RR; Stankowska DL; Dias HV; Yorio T
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1490-4. PubMed ID: 26832784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucomatous optic neuropathy: when glia misbehave.
    Neufeld AH; Liu B
    Neuroscientist; 2003 Dec; 9(6):485-95. PubMed ID: 14678581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide (NO): an emerging target for the treatment of glaucoma.
    Cavet ME; Vittitow JL; Impagnatiello F; Ongini E; Bastia E
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(8):5005-15. PubMed ID: 25125670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
    Marcic TS; Belyea DA; Katz B
    Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of curcumin against oxidative damage in BV-2 microglia and high intraocular pressure animal model.
    Yue YK; Mo B; Zhao J; Yu YJ; Liu L; Yue CL; Liu W
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):657-64. PubMed ID: 24963995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of non-IOP lowering therapy for glaucoma].
    Cybulska-Heinrich A; Mozaffarieh M; Flammer J
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):114-9. PubMed ID: 23430676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An activatable prodrug for the treatment of metastatic tumors.
    Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
    J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage.
    Liu Q; Ju WK; Crowston JG; Xie F; Perry G; Smith MA; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4580-9. PubMed ID: 17898281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma.
    Amankwa CE; Gondi SR; Dibas A; Weston C; Funk A; Nguyen T; Nguyen KT; Ellis DZ; Acharya S
    Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33917924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
    Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WK; Gale DC; Kucera DJ; Jia L; Prasanna G; Ongini E; Krauss AH; Impagnatiello F
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):125-32. PubMed ID: 20415621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esterase-activated chromane-sydnonimine prodrug hybrids.
    Vinatier V; Soulère L; Hoffmann P
    Nitric Oxide; 2006 Dec; 15(4):363-9. PubMed ID: 16644247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
    Morrison JC; Nylander KB; Lauer AK; Cepurna WO; Johnson E
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):526-31. PubMed ID: 9501862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
    Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antioxidant activity evaluation of novel β-elemene derivatives.
    Chen J; Duan W; Bai R; Yao H; Shang J; Xu J
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3407-11. PubMed ID: 24928401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.